NOVARTIS for NOVARTIS

Trade (domestic/foreign) TRD

Free Trade Agreements: - Intellectual Property Provisions in Panama, Colombia, Korea Access to Medicines Global Health Issues/Global Pandemic Influenza Planning

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: U.S. Agency for International Development (USAID); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Copyright/Patent/Trademark CPT

H.R.1249 - America Invents Act S.23 - America Invents Act Patent Settlement Legislation - 2011

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Taxation/Internal Revenue Code TAX

Orphan Drug Tax Credit

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Agency for International Development (USAID); SENATE; U.S. Trade Representative (USTR)

Health Issues HCR

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: H.R. 276 (112th), H.R. 759 (112th), S. 296 (112th), H.R. 452 (112th), S. 1232 (112th), H.R. 2245 (112th), H.R. 4702 (112th), H.R. 2923 (112th), H.R. 1548 (112th), H.R. 4872 (112th), H.R. 2190 (112th), H.R. 1259 (112th), H.R. 4990 (112th), S. 1206 (112th)

Medicare/Medicaid MMM

Access to Life Saving Medicines Act Provide Medicare Part B Coverage for Vaccines Covered under Part D Medicaid Coverage of Vaccines HR2 Children's Health Insurance Program Reauthorization Act of 2009 S 275 Children's Health Insurance Program Reauthorization Act of 2009 HR 2800 Imported Food Safety Improvement Act of 2009 Medicare Prescription Drugs and Modernization Act Immunosuppressant Legislation

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2800 (112th), H.R. 2 (112th)

Budget/Appropriations BUD

HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Commerce, Dept of (DOC); SENATE

Bills named: H.R. 1458 (112th), H.R. 1 (112th)

Labor Issues/Antitrust/Workplace LBR

Wage vs. Hour

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

Contacted: U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC)